CIPO trademark

INUBLISO

FiledCIPOWord markClass 5Class 10

"INUBLISO" is a word mark owned by Johnson & Johnson, filed at the CIPO on June 22, 2026. It is filed and waiting for examination and covers classes 5 and 10.

View Johnson & Johnson portfolioGet this data via the API
Official CIPO record
INUBLISO
Word mark as filed with the CIPO
Status
Filed
Since June 22, 2026
Filed
June 22, 2026
Registered
Not yet
Priority date
June 17, 2026
Claimed from United States
Application no.
2483616
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
2 classes
Ownership

Who owns INUBLISO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Johnson & Johnson

JNJ · United States

11,056 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services INUBLISO is filed for, grouped by Nice class.

  • Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, multiple sclerosis, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; Human pharmaceutical preparations for the prevention and treatment of hemolytic disease of the newborn; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, namely, antibacterials and antifungals, anti-allergic medications; human pharmaceutical preparations for the relief of pain

  • Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing pharmaceutical preparations into the human body; implantable drug delivery device

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Formalized
  2. Created
  3. Filed
FAQ

About INUBLISO

Who owns the trademark "INUBLISO"?

The CIPO trademark "INUBLISO" (application 2483616) is owned by Johnson & Johnson.

What is the status of "INUBLISO"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull INUBLISO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f0798-c224-731b-ba5c-b43722563373
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f0798-c224-731b-ba5c-b43722563373",
  "object": "trademark",
  "mark_text": "INUBLISO",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2483616",
  "filing_date": "2026-06-22",
  "nice_classes": [
    5,
    10
  ],
  "owners": [
    {
      "name": "JOHNSON & JOHNSON",
      "entity_id": "ent_019eb7ba-67fc-717e-bcfd-996931fa9380"
    }
  ]
}